Hiv Clinical Trial
— MBQROfficial title:
Developing and Testing Internet-Based Mindfulness Intervention to Reduce Minority Stress and Promote HIV-Related Behavioral Health Among Young Adult Sexual Minority Men: Aim 3, A Randomized Controlled Trial
The overall aim of the research study is to develop and test a mindfulness-based program for young adult gay, bisexual, and queer men at risk for HIV (Brown University IRB approved protocol #2004002698). Researchers have completed Aims 1 and 2 of the broader study. Aim 1 used qualitative, community engaged methods, along with a quantitative online survey, to inform intervention development with the study population. Aim 2 involved seeking feedback on the developed mindfulness program through an open-pilot with 18 participants from the same study population (young adult gay, bisexual, and queer men at risk for HIV). The next phase of the intervention development (Aim 3 - registered here) will enroll and randomize a sample of 60 distressed, high-risk YMSM into one of two groups: MBQR intervention (n=30) or active control condition (n=30). Researchers aim to over-enroll YMSM of color (e.g., Black/Latinx YMSM) and anticipate the group to include approximately 50-60% Black/Latinx YMSM (or YMSM of color). Primary outcomes are HIV and STI testing and self-reported sexual risk behaviors. Secondary outcomes are stress biomarker (fingernail cortisol levels), psychological health, minority stress and coping. The study will examine recruitment and retention, number of sessions attended, self-reported at-home practice of mindfulness, completion of assessment, and acceptability of the intervention.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | August 1, 2024 |
Est. primary completion date | January 1, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 34 Years |
Eligibility | Inclusion Criteria: - Assigned male at birth, - Being 18 to 34 of age, - Identify as a cisgender man or nonbinary, - Reside in the United States, - Can read and speak English, - Engaged in condomless anal sex with another man in past 6 months, - Endorse distress, measured by the PHQ-9 and GAD-7, - Possess a devise (phone, tablet, computer) that allows for online conferencing. - HIV-negative at time of screening Exclusion Criteria: Participants will be excluded from the study if they are determined to have symptoms that would prevent them from giving meaningful consent or participate in study activities including any of the following criteria: - Significant cognitive impairment - Psychosis - Currently symptomatic and untreated bipolar disorder - Imminent suicidal risk |
Country | Name | City | State |
---|---|---|---|
United States | Brown University | Providence | Rhode Island |
Lead Sponsor | Collaborator |
---|---|
Brown University | National Center for Complementary and Integrative Health (NCCIH) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Impact of MBQR intervention on HIV/STI testing: home testing | A primary aim of the study is to evaluate the impact of MBQR on HIV/STI testing through self-administered home testing kits provided at no cost to participants at baseline, post-intervention, and 6 months follow up.
At baseline, participants will participate in rapid oral HIV testing. Kits will be mailed to participants and with be completed at home on Zoom with study research assistants available for guidance and testing counseling (as needed). At post-intervention and 6 month follow-up, participants will be asked to complete more comprehensive home HIV/STI testing. |
6 months | |
Primary | Impact of MBQR intervention on HIV/STI testing: self report | A primary aim of the study is to evaluate the impact of MBQR on HIV/STI testing through self-report measures adminisiterd via Qualtrics.
At baseline, post-intervention, and 6-month follow up, all participants will be invited to complete an intervention assessment via Qualtrics. This assessment contains a HIV/STI status and testing experience questionnaire. |
6 months | |
Primary | Impact of MBQR intervention on sexual risk behaviors | A primary aim of the study is to evaluate the impact of MBQR on sexual risk behaviors.
This primary outcome will be assessed via the Sexual Risk Behaviors Scale, which is adapted from Emory University's American Men's Internet Survey. At baseline, mid-intervention (week 5), post-intervention, and 6-month follow up, participants will complete an intervention assessment via Qualtrics. This assessment will contain the Sexual Risk Behaviors Scale. |
6 months | |
Primary | Impact of MBQR intervention on safe sex behaviors | A primary aim of the study is to evaluate the impact of MBQR on safe sex behaviors.
This primary outcome will be assessed via the Safe Sex Self-Efficacy Scale (SSES). Participants will respond to 13 items using a five item Likert scale (1=Not at all confident, 2=Not very confident, 3=Somewhat confident, 4=Very confident, 5=Extremely confident). Scores may range from 13-65. At baseline, post-intervention, and 6-month follow up, participants will complete an intervention assessment via Qualtrics. This assessment will contain the Safe Sex Self-Efficacy Scale (SSES). |
6 months | |
Primary | Feasibility of online MBQR as measured by recruitment rates | A primary aim of the study is to evaluate feasibility and acceptability of MBQR. Feasibility will be assessed via three measures. One measure of feasibility will be participant recruitment rates. See other primary outcomes for other measures used. | 3 months | |
Primary | Feasibility of online MBQR as measured by retention rates | A primary aim of the study is to evaluate feasibility and acceptability of MBQR. Feasibility will be assessed via three measures. One measure of feasibility will be participant retention rates (i.e., as measured by attendance and attrition). See other primary outcomes for other measures used. | 3 months | |
Primary | Feasibility of online MBQR as measured by engagement: Enactment of treatment skills | A primary aim of the study is to evaluate feasibility and acceptability of MBQR. Feasibility will be assessed via three measures. One measure of feasibility will be engagement (i.e, enactment of treatment skills), which will be assessed by home practice completion. | 3 months | |
Primary | Acceptability of online MBQR as measured by the Client Satisfaction Questionnaire | A primary aim of the study is to evaluate feasibility and acceptability of MBQR. Acceptability will be assessed using three measures. One such measure of acceptability will be via acceptability ratings using the validated 8-item Client Satisfaction Questionnaire (CSQ-8). Scores for the CSQ-8 range from 8 to 32, with higher values indicating higher satisfaction. See other primary outcomes for other measures used. | 3 months | |
Primary | Acceptability of online MBQR as measured by a session evaluation form | The primary aim of the study is to evaluate feasibility and acceptability of MBQR. Acceptability will be assessed using three measures. One such measure of acceptability will be via a session evaluation form that provides both qualitative and quantitative feedback on the study intervention. See other primary outcomes for other measures used. | 3 months | |
Primary | Acceptability of online MBQR as measured by semi-structured qualitative exit interview | The primary aim of the study is to evaluate feasibility and acceptability of MBQR. Acceptability will be assessed using three measures. One such measure of acceptability will be via a semi-structured qualitative exit interview conducted with one-on-one with study participants via a videoconferencing platform (i.e., Zoom). Interviews will be transcribed and coded for analysis. | 3 months | |
Secondary | Fingernail cortisol levels | This secondary outcome will be assessed by providing participants with a fingernail collection kit from which a cortisol bio-sample (i.e., nail trimmings) can be used to assess participant cortisol stress levels during the study.
Participants will submit bio-samples via a nail collection kit at baseline, post-intervention, and 6-month follow up. |
6 months | |
Secondary | Depression symptoms: PHQ-9 | This secondary outcome will be assessed via the 9-item Patient Health Questionnaire (PHQ-9). Participants will respond to each item using a four item Likert scale (0=Not at all, 1=Several days, 2=More than half the days, 3=Nearly every day). Scores range from 0-27 with cut points indicating minimal (1-4), mild (5-9), moderate (10-14), moderately severe (15-19), and severe (20-27) depression. Since the questionnaire relies on patient self-report, all responses should be verified by a clinician.
Participants will complete the PHQ-9 at baseline, weekly during the intervention, at post-intervention, and at 6-month follow up. |
6 months | |
Secondary | Depression symptoms: BDI-II | This secondary outcome will be assessed via the 21-item Beck Depression Inventory II (BDI-II). Each item is rated on a 4-point Likert-type scale ranging from 0 to 3, based on the severity in the last two weeks. Total scores range from 0 to 63 with higher scores suggesting higher levels of depression symptomology; Total score of 0-13 is considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe..
Participants will complete the BDI-II at baseline, post-intervention, and at 6-month follow up. |
6 months | |
Secondary | Anxiety symptoms | This secondary outcome will be assessed using the 7-item, self-reported Generalized Anxiety Disorder Assessment (GAD-7). Participants will report on anxiety symptoms using a four item Likert scale (0=Not at all, 1=Several days, 2=More than half the days, 3=Nearly every day). Scores range from 0-21, with scores of 5, 10, and 15 serving as cut-off points for mild, moderate and severe anxiety, respectively. When used as a screening tool, further evaluation is recommended when the score is 10 or greater. Since the questionnaire relies on patient self-report, all responses should be verified by a clinician.
Participants will complete the GAD-7 at baseline, weekly during the intervention, at post-intervention, and at 6-month follow up. |
6 months | |
Secondary | Perceived stress | This secondary outcome will be assessed using the 10-item, self-reported Perceived Stress Scale (PSS-10). Participants will report on thoughts and feeling during the past month using a five item Likert scale (0=Never, 1=Almost Never, 2=Sometimes, 3=Fairly Often, 4=Very Often). Scores may range from 0-40.
Participants will complete the PSS-10 at baseline, post-intervention, and 6-month follow up. |
6 months | |
Secondary | Loneliness | This secondary outcome will be assessed using the 20-item, self-reported UCLA Loneliness Scale. Participants will respond to 20 items on a four point Likert scale (1=Never, 2=Rarely, 3=Sometimes, 4=Sometimes). Scores may range from 20-80.
Participants will complete the UCLA Loneliness Scale at baseline, post-intervention, and 6-month follow up. |
6 months | |
Secondary | Mindfulness | This secondary outcome will be assessed using the Mindful Attention Awareness Scale (MAAS). Participants will respond to 15 items on a six point Likert scale (1=Almost Always, 2=Very Frequently, 3=Somewhat Frequently, 4=Somewhat Infrequently, 5=Very Infrequently, 6=Almost Never). Scores range from 15 to 90 with higher scores reflecting higher levels of dispositional mindfulness.
Participants will complete the MAAS at baseline, post-intervention, and 6-month follow up. |
6 months | |
Secondary | Self compassion | This secondary outcome will be assessed using the 26-item validated Self-Compassion Scale (SCS); Participants indicate how they typically act towards themselves in difficult times using a 5-point Likert scale with 1 being "Almost Never" to 5 being "Almost Always". The total self-compassion score is calculated by reverse scoring the negative sub-scale items - self-judgment, isolation, and over-identification (i.e., 1 = 5, 2 = 4, 3 = 3, 4 = 2, 5 = 1) then computing a total mean. Researchers can choose to analyze their data either by using individual sub-scale sores or by using a total score.
Participants will complete the SCS at baseline, post-intervention, and 6-month follow up. |
6 months | |
Secondary | Emotion regulation difficulties | This secondary outcome will be assessed using the Difficulties in Emotion Regulation Short Form Scale (DERS-SF). The DERS-SF is an 18-item self-report measure of six facets of emotion regulation. Items are rated on a scale of 1-5, with 1 being ("almost never [0-10%]"); 2 ("sometimes [11-35%]"); 3 ("about half the time [36-65%]"); 4 ("most of the time [66-90%]); and 5 being ("almost always [91-100%]"). Higher scores indicate more difficulty in emotion regulation.
Participants will complete the DERS-SF at baseline, post-intervention, and 6-month follow up. |
6 months | |
Secondary | Queer community belonging | This secondary outcome will be assessed using the nine-item Queer Community Belonging scale. Participants rate nine items on a five point Likert scale (1=not at all or never, 2=almost never or occasionally, 3=some of the time, 4=most of the time, 5=all of the time). Scores may range from 9-40.
Participants will complete the self-report scale at baseline, post-intervention, and 6-month follow up. |
6 months | |
Secondary | PrEP willingness and adherence | This secondary outcome will be assessed using a five-item Pre-Exposure Prophylaxis (PrEP) history and willingness questionnaire. Additionally, participants will complete a six item PrEP adherence self-efficacy questionnaire.
Participants will complete the self-report questionnaires at baseline, post-intervention, and 6-month follow up. |
6 months | |
Secondary | Sleep | This secondary outcome will be assessed using the Brief Pittsburgh Sleep Inventory (PSI-SF). The PSI-SF is an 10-item self-report measure a participant's usual sleep habits during the past month.
Participants will complete the PSI-SF at baseline, post-intervention, and 6-month follow up. |
6 months | |
Secondary | Internalized Stigma/Homophobia | Internalized Stigma/Homophobia will be assessed using the self-report 9-item Internalized Homophobia Scale (IHS) that measures perceived and experienced stigma in the past 12 months using a four point scale (1=Never, 2=Rarely, 3=Sometimes, 4=Often). Scores range from 9 to 36 with higher scores indicating higher internalized stigma.
Participants will complete the IHS at baseline, post-intervention, and 6-month follow up. |
6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |